Strong US dollar hurts Swiss pharmaceutical company Novartis with 32-per cent drop in Q2 profit + MORE Jul 21st

There are more investment options in Canada than you can shake a stick at! Stay on top of the best returns right here.
Latest News

Blake Lively and Ryan Reynolds provide financial support for refugees - Entertainment News - Castanet.net Feb 27th

Blake Lively and Ryan Reynolds provide financial support for refugees - Entertainment News  Castanet.netSupporting Ukraine: Canadians opening wallets  CTV NewsBlake Lively and Ryan Reynolds Promise to Match Donations to Ukrainian Refugees Up to $1 Million  PEOPLERyan Re.... More »
 money market

Financial independence and travel: Can you have both? Apr 24th

In February and early March, as is increasingly our custom, my wife Ruth and I spent five weeks in a sunny clime in order to avoid the tail end of Canada’s winter. On our return from Malta, regular guest blogger Devin Partida contributed a relevant article titled “Can you pursue financial indepe.... More »

All of Canada would pay the price if Toronto’s real estate bubble burst Apr 8th

Real estate figures in the country’s largest city are at red-hot levels, and the rest of Canada will ultimately have to pay for it .... More »

Business Highlights + MORE Jul 1st

___ As desire to acquire mounts, so does risk of losses NEW YORK (AP) — Goodwill — mankind needs more of it, but there may be far too much in the financial world. Goodwill is the accounting term for the premium that companies pay when they buy each other, over the value of the actual assets bein.... More »

Why healthy money conversations are key to building wealth together Jul 8th

When it comes to building wealth, most people focus on investments, debt levels, or market performance. But what if the real threat to your financial future isn’t any of those? According to Co-authors of Money Together, Heather and Douglas Boneparth, the biggest risk is hiding in plain sight: the .... More »
TOKYO – Toshiba’s chief executive resigned Tuesday to take responsibility for doctored books that inflated profits at the Japanese technology manufacturer by 152 billion yen ($1.2 billion) over several years.
Toshiba Corp. acknowledged a systematic coverup, which began in 2008. Various parts of the Japanese company’s sprawling business including computer chips and personal computers were struggling financially, but top managers set unrealistic earnings targets under the banner of “challenge,” and subordinates faked results.
On top of its struggles in electronics, Tokyo-based Toshiba’s prospects in nuclear power, one of its core businesses, were shaken after the 2011 Fukushima disaster set off public fears about reactor safety, making new nuclear plants unlikely in Japan. All 48 of the nation’s working reactors are now offline.
Bowing deeply before flashing cameras at a news conference, CEO Hisao Tanaka kept his head lowered for nearly half a minute in a gesture meant to convey deep shame and contrition…

Continue Reading On canadianbusiness.com »

The best of the web on money, markets and all things financial, as chosen daily by Globe and Mail personal finance columnist Rob Carrick

Continue Reading On theglobeandmail.com »

Beware the hype of the next big deal

– theglobeandmail.com

The financial crisis was supposed to teach us about falling for resource boom hype, yet CEOs make the same mistakes over and over again

Continue Reading On theglobeandmail.com »

BERLIN – Swiss-based pharmaceutical giant Novartis’ second-quarter net income dropped 32 per cent over the same quarter last year, brought down primarily by poor performance from associated companies and negative effects of a strong U.S. dollar, the company said Tuesday
Net income was $1.856 billion, down from $2.723 billion in the same quarter in 2014. Net sales were down 5 per cent to $12.694 billion and earnings per share from continuing operations dropped to $0.77 from $1.11 last year.
Nevertheless, CEO Joseph Jimenez said the company had a strong quarter for innovation with the U.S. approval and launch of two new drug products — heart failure drug Entresto and multiple sclerosis therapy drug Glatopa — and confirmed its full-year guidance.
Group sales are expected to grow by mid-single digits and operating income is expected to grow ahead of sales at a high-single-digit rate, Novartis has said.
“We are confident we will deliver on our priorities for the year,” Jimenez said…

Continue Reading On canadianbusiness.com »

Drug makers lead European stocks slightly lower; crude oil continues to skid on oversupply concerns

Continue Reading On theglobeandmail.com »

Share

PinIt
Compare insurance quotes through Kanetix.ca - save time and money!